| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/29/2010 | WO2010017248A3 Sting (stimulator of interferon genes), a regulator of innate immune responses |
| 04/29/2010 | WO2010017198A3 Fgfr extracellular domain acidic region muteins |
| 04/29/2010 | WO2010016944A3 Analogues of glucose-dependent insulinotropic polypeptide (gip) modified at n-terminal |
| 04/29/2010 | WO2010011994A3 Polypeptides and uses thereof |
| 04/29/2010 | WO2010011947A3 AMYLOID ß PEPTIDE ANALOGUES, OLIGOMERS THEREOF, PROCESSES FOR PREPARING AND COMPOSITIONS COMPRISING SAID ANALOGUES OR OLIGOMERS, AND THEIR USES |
| 04/29/2010 | WO2010011693A3 Proteins containing expanded polyglutamine tracts induce mitochondrial fragmentation by disrupting mitochondrial fusion |
| 04/29/2010 | WO2010009227A3 Recombinant pokeweed antiviral proteins, compositions and methods related thereto |
| 04/29/2010 | WO2010007551A3 Method for the production of tenocytes in vitro from mesenchymal stem cells |
| 04/29/2010 | WO2010006804A8 Method to obtain transgenic plants resistant to phytopathogen attack based on rna interference (rnai) |
| 04/29/2010 | WO2010002283A3 New insulin analogues of prolonged activity |
| 04/29/2010 | WO2009158470A3 Toxin genes and methods for their use |
| 04/29/2010 | WO2009147538A3 Dense and erect panicle gene and uses thereof |
| 04/29/2010 | WO2009144462A3 Laminin receptor binding proteins |
| 04/29/2010 | WO2009133099A3 Insulin precursors for oral diabetes treatment |
| 04/29/2010 | WO2008012525A8 Derivatisation of granulocyte colony-stimulating factor |
| 04/29/2010 | US20100107264 Development of influenza a antivirals |
| 04/29/2010 | US20100105882 Molecular module |
| 04/29/2010 | US20100105878 Hybrid Hepatocyte Growth Factor Gene Having High Expression Efficiency of Two Heterotypes of Hepatocyte Growth Factor |
| 04/29/2010 | US20100105876 Method for the oligomerisation of peptides |
| 04/29/2010 | US20100105872 Partially hydrolysed cereal protein |
| 04/29/2010 | US20100105871 Glycoalkaloid removal |
| 04/29/2010 | US20100105870 Method Of Complexing A Protein By The Use Of A Dispersed System And Proteins Thereof |
| 04/29/2010 | US20100105869 Physiologically Active Polypeptide Conjugate Having Prolonged In Vivo Half-Life |
| 04/29/2010 | US20100105868 Method for detecting neuroblastoma |
| 04/29/2010 | US20100105867 Process for producing osteocalcin-containing extract |
| 04/29/2010 | US20100105865 Nucleic acids and proteins from streptococcus groups a & b |
| 04/29/2010 | US20100105863 Method For Producing Acylated Peptides |
| 04/29/2010 | US20100105625 Product and Methods for Diagnosis and Therapy for Cardiac and Skeletal Muscle Disorders |
| 04/29/2010 | US20100105624 Calcitonin drug-oligomer conjugates, and uses thereof |
| 04/29/2010 | US20100105623 Schizophrenia-related isoform of kcnh2 and development of antipsychotic drugs |
| 04/29/2010 | US20100105620 Polypeptides that bind Trail-R1 and Trail-R2 |
| 04/29/2010 | US20100105619 Cysteine-containing peptides having antioxidant properties |
| 04/29/2010 | US20100105618 Non-Natural Recombinant Gelatins with Enhanced Functionality |
| 04/29/2010 | US20100105616 Polyethylene glycol-g-csf conjugate |
| 04/29/2010 | US20100105612 Agent containing fused protein of soluble rankl with epitope tag |
| 04/29/2010 | US20100105610 Methods of Inhibiting Tumor Cell Aggressiveness Using the Microenvironment of Human Embryonic Stem Cells |
| 04/29/2010 | US20100105609 Processes for Preparing Eptifibatide |
| 04/29/2010 | US20100105606 Methods for making high oxygen affinity modified hemoglobin for oxygen transport |
| 04/29/2010 | US20100105567 Novel capture agents for binding a ligand |
| 04/29/2010 | US20100105151 Novel Druggable Regions in the Dengue Virus Envelope Glycoprotein and Methods of Using the Same |
| 04/29/2010 | US20100105141 Sulfonylurea-Responsive Repressor Proteins |
| 04/29/2010 | US20100105136 Chimeric t-cell receptors and t-cells targeting egfrviii on tumors |
| 04/29/2010 | US20100105123 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same |
| 04/29/2010 | US20100105117 Gene associated with foam formation of acetic acid bacterium, acetic acid bacterium bred by modifying the gene and method for producing vinegar using the acetic acid bacterium |
| 04/29/2010 | US20100105078 Compositions And Methods Of A Phosphatidic Acid Binding Protein |
| 04/29/2010 | US20100105077 Means for Detection and Purification of CD8+ T Lymphocyte Populations Specific to Peptides Presented in the Context of HLA |
| 04/29/2010 | US20100105070 Diagnosis and treatment of preeclampsia |
| 04/29/2010 | US20100105051 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| 04/29/2010 | US20100104603 Use of staphylococcal superantigen-like protein 5 (ssl5) in medicine |
| 04/29/2010 | US20100104594 Pathogen for bacterial poultry disease |
| 04/29/2010 | US20100104592 Hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 04/29/2010 | US20100104591 Polypeptides for inducing a protective immune response against staphylococcus epidermidis |
| 04/29/2010 | US20100104582 CD200 and its receptor, CD200R, modulate bone mass via the differentiation of osteoclasts |
| 04/29/2010 | US20100104576 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response; immunization; |
| 04/29/2010 | US20100104574 Frizzled-Binding Agents and Uses Thereof |
| 04/29/2010 | US20100104568 Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders |
| 04/29/2010 | US20100104560 Botulinum neurotoxin e receptors and uses thereof |
| 04/29/2010 | US20100104536 P38 inhibitors |
| 04/29/2010 | US20100104535 Drug delivery; sustained, high-level expression of a delivered nucleotide sequence encoding erythropoietin, and for in vivo secretion thereof from transduced muscle cells such that systemic delivery |
| 04/29/2010 | US20100104531 Homogeneous preparations of il-28 and il-29 |
| 04/29/2010 | US20100104529 TNF-alpha VACCINE FOR TREATING DISEASE CONDITIONS MEDIATED BY PATHOLOGICAL TNF-alpha |
| 04/29/2010 | DE102008053284A1 Stabilizer, useful for stabilizing heparin-binding growth factors and for manufacturing medicament e.g. for wound healing and bone regeneration, comprises a compound having an oligophosphate group |
| 04/29/2010 | CA2741523A1 Human ebola virus species and compositions and methods thereof |
| 04/29/2010 | CA2741399A1 Rab6kifl/kif20a epitope peptide and vaccines containing the same |
| 04/29/2010 | CA2741333A1 Vaccine against african horse sickness virus |
| 04/29/2010 | CA2741285A1 Mutated eif4e sequences from potato which are useful in imparting virus resistance |
| 04/29/2010 | CA2741190A1 High-throughput assay for evaluating dipeptidyl peptidase i activity |
| 04/29/2010 | CA2741098A1 Peptide derivatives and use thereof as carriers for molecules in the form of conjugates |
| 04/29/2010 | CA2740241A1 Prostate stem cells and uses thereof |
| 04/29/2010 | CA2674454A1 Improved hcv vaccines and methods for using the same |
| 04/28/2010 | EP2180054A1 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 04/28/2010 | EP2180053A2 Wisp polypeptides and therapeutical applications thereof |
| 04/28/2010 | EP2180045A1 Novel protein highly producing recombinant animal cell, method for preparing the same and method for mass-producing protein using the same |
| 04/28/2010 | EP2180041A2 New lines of human hepatomas, methods for obtaining same and applications thereof |
| 04/28/2010 | EP2180009A1 B-domain-deleted recombinant human Factor VIII. |
| 04/28/2010 | EP2179996A1 Sulfonated diarylrhodamine dyes |
| 04/28/2010 | EP2179742A1 Compositions and methods for the treatment of immune related diseases |
| 04/28/2010 | EP2179730A1 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 04/28/2010 | EP2179043A2 Transgenic plants with increased stress tolerance and yield |
| 04/28/2010 | EP2179042A2 Late blight resistance genes and methods |
| 04/28/2010 | EP2178920A1 An anti-cancer cytotoxic monoclonal antibody |
| 04/28/2010 | EP2178913A1 Antibody or fragment thereof recognizing avitag(tm) and uses thereof |
| 04/28/2010 | EP2178912A1 Insulin analogues with an acyl and aklylene glycol moiety |
| 04/28/2010 | EP2178911A2 Rapid acting insulin analogues |
| 04/28/2010 | EP2178910A1 Insulins with an acyl moiety comprising repeating units of alkylene glycol containing amino acids |
| 04/28/2010 | EP2178909A1 Rapid acting insulin analogues |
| 04/28/2010 | EP2178907A1 Thiopeptide precursor protein, gene encoding it and uses thereof |
| 04/28/2010 | EP2178905A1 Methods of activiting clostridial toxins |
| 04/28/2010 | EP2178904A1 Psm peptides as vaccine targets against methicillin-resistant staphylococcus aureus |
| 04/28/2010 | EP2178903A2 Optimized dengue virus entry inhibitory peptide (dn81) |
| 04/28/2010 | EP2178559A2 Recombinant vibrio cholerae exotoxins |
| 04/28/2010 | EP2178558A2 Yersinia pestis antigens, vaccine compositions, and related methods |
| 04/28/2010 | EP2178548A1 Survivin peptides as cancer vaccines |
| 04/28/2010 | EP1756286B1 Maize multidrug resistance-associated protein polynucleotides and methods of use |
| 04/28/2010 | EP1730179B1 Novel mannose-specific adhesins and their use |
| 04/28/2010 | EP1730175B1 Optimized expression of hpv 52 l1 in yeast |
| 04/28/2010 | EP1635859B1 Therapeutic use of pam |
| 04/28/2010 | EP1556513B1 Compositions and methods for treating human papillomavirus-mediated disease |
| 04/28/2010 | EP1546362B1 Apolipoprotein e stable folding intermediate and methods of use thereof |
| 04/28/2010 | EP1539960B1 Protease-resistant modified interferon alpha polypeptides |